WHC is still in active development. Read this to understand our approach.
depiction of SPCIYGNTAMCTRO-UHFFFAOYSA-N.svg
tripsit

psilocin

Verificar en tripsit

psychonaut

Psilocin

Verificar en psychonaut

isomerdesign

Psilocin

Verificar en isomerdesign

druglab

Psilocin

Verificar en druglab

drugmap

PSILOCIN

Verificar en drugmap

wiki

Psilocin

Verificar en wiki

Data

InChI: InChI=1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3

Sinónimos: INDOL-4-OL, 3-(2-(DIMETHYLAMINO)ETHYL)-, UNII-CMS88KUW0G,4-Hydroxy-N,N-dimethyltryptamine,CAS-520-53-6,EN-0002,L000675,N,N-Dimethyl-4-hydroxytryptamine, CX-59,P-7800,Psilocin,PSILOCIN,DSSTox_RID_83094,GTPL11291,Psilocin solution, 100 mug/mL in methanol, drug standard, P-7800, 3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol,BRN 0160503, CHEBI:8613, EINECS 208-296-5, NCGC00247728-01,Psilocine, 3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol,1H-Indol-4-ol, 3-[2-(dimethylamino)ethyl]-,NCGC00247728-01,DSSTox_CID_28825,3-[2-(Dimethylamino)ethyl]-Indol-4-ol,PSILOCIN [WHO-DD],4-HO-DMT,Magic mushrooms (Salt/Mix),Psilocin/psilocybin (Salt/Mix),4-OH-DMT,INDOL-4-OL, 3-(2-(DIMETHYLAMINO)ETHYL)-, 3-(2-(Dimethylamino)ethyl)indol-4-ol,520-53-6,Psilocyn,Psilocin, vial of 5 mg, certified reference material,PSOH,PSILOCIN [MART.],PAL-153,CMS88KUW0G,Tryptamine, 4-hydroxy-N,N-dimethyl,Q409150,5-22-12-00014 (Beilstein Handbook Reference),CX 59, 4-OH-DMT,EINECS 208-296-5, CHEMBL65547,N,N-Dimethyl-4-hydroxy-tryptamine,SCHEMBL194899,UNII-CMS88KUW0G,DEA No. 7438, Indol-4-ol, 3-[2-(dimethylamino)ethyl]-,3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-ol,4-oh-dmt,4-HYDROXY-N,N-DIMETHYLTRYPTAMINE PSILOCIN,91Q,CHEBI:8613,3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol #,C08312,DSSTox_GSID_48899, Psilocin solution, 4-Hydroxy-N,N-dimethyltryptamine,3-(2-(Dimethylamino)ethyl)indol-4-ol,4-Indolol, 3-[2-(dimethylamino)ethyl],Tox21_112894,CX-59,N,N-Dimethyl-4-Hydroxytryptamine,ZINC2001, CMS88KUW0G, Psilocine,Psilotsin,3-[2-(Dimethylamino)ethyl]-4-indolol, Psilocyn, 1H-Indol-4-ol, 3-[2-(dimethylamino)ethyl]-,BDBM50081701,CHEMBL65547,AKOS022505992, 520-53-6, Psilotsin,4-ho-dmt,3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol,Indol-4-ol, 3-[2-(dimethylamino)ethyl]-,3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol,PSILOCIN [MI],DTXSID5048899, N,N-Dimethyl-4-Hydroxytryptamine, BRN 0160503,DTXCID5028825,Psilocin solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, DEA No. 7438, AC1L1JCI,SPCIYGNTAMCTRO-UHFFFAOYSA-

Estimated data

Solubilidad: -1.468 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 93.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.